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de Araújo Júnior RF, de Araújo AA,
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Inflammatory bowel diseases, mainly ulcerative colitis and Crohn’s disease are characterized
by chronic inflammation in the intestine. Currently several therapeutic strategies available to
treat inflammatory bowel diseases. Though, most treatments can be associated with serious
adverse effects what justifies the search for new treatments. In this sense, we highlight the
interest in herbal products rich in bioactive compounds which immunomodulatory and
antioxidant properties as is the case of Bryophyllum pinnatum (Crassulaceae). This plant is
used in traditional medicine in Brazil for treating inflammatory diseases. We hypothesized
that hydroethanolic B. pinnatum leaf extract has intestinal anti-inflammatory effects on two
experimental colitis models: 2.4-dinitrobenzene sulfonic acid (DNBS) in rats, and dextran
sulfate sodium (DSS) in mice. Ultra-fast liquid chromatography method used for the
quantification of the main compounds indicated good linearity, specificity, selectivity,
precision, robustness and accuracy. The major flavonoids (mg/g of the extract) quantified
were: quercetin 3-O-a-L-arabinopyranosyl-(1!2)-a-L-rhamnopyranoside (35.56 ± 0.086
mg/g), kaempferol 3-O-a-L-arabinopyranosyl-(1!2)-a-L-rhamnopyranoside (4.66 ± 0.076
mg/g) and quercetin-3-O-rhamnopyranoside (4.56 ± 0.026 mg/g). The results obtained in
the DNBS and DSS models indicate that extract has both chemopreventive and anti-
inflammatory effects, observing a significant reduction in the disease activity index score, and
less macroscopic and microscopic damage. The extract promoted downregulation of Toll-
like receptor and kappa B p65 nuclear factor gene expression, leading to a reduction inin.org July 2020 | Volume 11 | Article 9981
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Frontiers in Pharmacology | www.frontierspro-inflammatory and oxidative mediators, chemokines, and cell adhesion molecules. This
immunomodulatory property was proposed that one of the possible action mechanisms of
extract. An improvement in intestinal damage was also associated with a reduction in
oxidative stress and infiltration of leukocytes, as evidenced by the reduction in
malonaldialdehyde and myeloperoxidase activity and increase in total glutathione in the
colonic tissue. Moreover, the extract improved the cytoarchitecture of the colonic tissue and
the integrity of the intestinal epithelial barrier by restoring the expression of the proteins
associated with mucosa protection. In view of the beneficial effects showed by the B.
pinnatum leaf extract in preclinical rodent models of colitis there is the potential to conduct
some future clinical studies to ensure safe and effective development of a phytotherapeutic
treatment for human inflammatory bowel diseases.Keywords: 2.4-dinitrobenzene sulfonic acid, dextran sulfate sodium, herbal drug, flavonoid, inflammatory bowel
diseases, immune response, oxidative stressINTRODUCTION
Ulcerative colitis (UC) and Crohn’s disease (DC) are inflammatory
bowel diseases (IBD) referring to chronic idiopathic diseases of the
gastrointestinal tract, being characterized by chronic and recurrent
inflammation of the intestine (Wu et al., 2020). Its etiology is not
yet fully understood, but it is most likely related to genetic and
environmental factors, changes in the composition of the intestinal
microbiota and an exacerbated and abnormal immune response
(Pallio et al., 2016). This altered immune response promotes an
increase in inflammatory mediators responsible for generating and
maintaining inflammation in IBD, including pro-inflammatory
cytokines such as interleukin (IL)-1b, IL-6, IL-17, tumor necrosis
factor (TNF) a, prostaglandins, and nitric oxide (NO). Previous
studies have found strong evidence that increased expression of
kappa B p65 nuclear factor (NF-kB p65), a transcription factor
involved in controlling the expression of several genes linked to the
inflammatory response, is followed by increased capacity of
defense cells (neutrophils and macrophages) to produce and secrete
TNF-a, IL-1b, and IL-6, chemokines [monocyte chemoattractant
protein-1 (MCP-1) and macrophage inflammatory protein-2 (MIP-
2)], cell adhesion molecules [type I intercellular adhesion molecules
(ICAM-1)], eicosanoids, and increases the oxidative stress by reactive
oxygen (ROS) and nitrogen (RNS) species on cells (Lu et al., 2018;
Wang et al., 2018).
In IBD, chronic inflammation occurs because acute
inflammatory mechanisms cannot eliminate tissue injury. In this
process, germline-encoded pattern-recognition receptors (PRRs)
are activated in both immune and non-immune cells. Classes of
PRR families include Toll-like receptors (TLRs). TLRs are a family
of highly conserved, mammalian PRRs which participate in
activating the inflammatory response. TLRs can mediate the
differentiation of T-cells into effector T helper (Th or CD4+)
cells, including Th1, Th2, and Th17 cell types and proliferate
macrophages, thus impairing the intestinal mucosa. Furthermore,
signaling through TLRs activates an intracellular signaling cascade
which leads to nuclear translocation of transcription factors such
as NF-kB p65 (Chen et al., 2018). Nitric oxide synthase (NOS) inin.org 2the inducible isoform (iNOS) is highly expressed by immune cells
(e.g. macrophages) after activation of NF-kB p65 in response to
many stimuli, including TNF-a, interferon gamma, IL-6, IL-1b,
bacterial, and viral components. L-arginine then generates NO by
oxidizing the amino acid, which exerts protective effects during
acute experimental colitis. The high levels of iNOS and
consequently NO released in the mucosa in IBD cause severe
tissue damage and intensified inflammation (Soufli et al., 2016).
The intestinal epithelium forms the physical, protective, and host
defense barrier against the harmful luminal microenvironment. The
epithelium is covered by a single-cell layer composed of different
subtypes of specialized intestinal epithelial cells (IEC) including
goblet cells, Paneth cells enteroendocrine cells, enterocytes, M cells,
cup cells, and Tuft cells (Garcia-Carbonell et al., 2019). These IEC,
especially the goblet cells produce secretory [mucin type II (MUC-
2)] and membrane-associated mucins [mucin type III (MUC-3)],
villin (actin regulatory protein), and trefoil factors [trefoil factor 3
(TFF-3)], which are responsible for cell morphology and epithelial
restitution (Algieri et al., 2013; Dorofeyev et al., 2013). Moreover,
the junctional complexes cells in the mucosal epithelium forms
physiologically active barrier mediated by a cluster of proteins,
including zonula occludens type 1 (ZO-1) and occludin (tight
junctions complex) that can change intestinal permeability (Poritz
et al., 2007). Bioactive or epigenetic factors such as microbes, toxins,
and pro-inflammatory cytokines, promoting a rupture in the barrier
and loss of proper mucins (MUC-2 and MUC-3) secretion which
leads to chronic inflammation in IBD (Okamoto and Watanabe,
2016; Garcia-Carbonell et al., 2019).
Patients with IBD present abdominal pain and bloody
diarrhea, and the disease has a long course. Recurrence is
common, along with severe complications and poor prognosis
by pharmacological treatment (Wu et al., 2020). The
pharmacological treatments for human IBD mainly comprise
anti-inflammatory and immunosuppressive drugs, which can be
linked to significant side effects, thus limiting their use (Pagnini
et al., 2019). There is consequently a clear demand for new
treatments which combine efficacy and safety, such as those of
natural origin. Applications of medicinal plants in both theJuly 2020 | Volume 11 | Article 998
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been widely described in the literature (Kim et al., 2018).
Specifically regarding Bryophyllum pinnatum, its use has been
recognized in in vivo studies to treat some inflammatory diseases
and for healing wounds (dos Santos Nascimento et al., 2018;
Fernandes et al., 2019).
B. pinnatum (Lamark) (synonym B. calycinum and Kalanchoe
pinnata (Lamk) Pers.), Crassulaceae family, popularly known as
“saião” and “coirama”, is widely used in traditional medicine
worldwide, mainly in treating inflammatory, gastritis, and ulcer
problems (The Plant List, 2010; Fernandes et al., 2019). B.
pinnatum is rich in phenolic compounds, especially quercetin-
and kaempferol-derived flavonoid glycosides, which are
responsible for some of these aforementioned biological
activities, and other secondary metabolites such as terpenes,
steroids, and bufadienolides (Muzitano et al., 2006; Cruz et al.,
2012; Fernandes et al., 2016; de Araújo et al., 2019). In acute
toxicity studies (14 days; using albino Swiss and BALB/c mice)
with ethanolic and aqueous B. pinnatum extracts (administered
orally) conducted as per Organization for Economic Co-operation
and Development (OECD) guidelines, no mortality, noticeable
behavioral, or biochemistry analysis changes were observed in any
of the tested groups. The extracts were found to be safe up to 2000
mg/kg body weight with no mortality, thus the 1/8 and 1/4 doses
(i.e., 250 mg/kg and 500 mg/kg) can be selected for all further in
vivo studies (Torres-Santos et al., 2003; Afzal et al., 2013).
It is important to mention that this species is included on the
National List of Medicinal Plants of Interest to the Brazilian
Public Health System (RENISUS), which is a report published by
the Brazilian health ministry which includes medicinal plants
which can be used in the near future by the population and for
developing phytotherapeutic medicines (Brasil, 2009). Although
B. pinnatum is widely used by traditional medicine practitioners,
its chemical constituents have not been fully elucidated. Few
investigations have involved isolating and elucidating its
bioactive compounds until now, but most of the studies have
indicated the presence of glycosylated flavonoids, with acetylated
rhamnose sugar linked to different positions of aglycone
(Fernandes et al., 2019).
Among the constituents analyzed in B. pinnatum leaf, quercetin
3-O-a-L-arabinopyranosyl-(1!2)-a-L-rhamnopyranoside (Bp1)
was the first compound isolated for this specie (Muzitano et al.,
2006), and it is the major compound reported in literature (Sobreira
et al., 2017; dos Santos Nascimento et al., 2018). Fernandes et al.
(2019) and Ferreira et al. (2014) reported other compounds already
described for B. pinnatum: kaempferol 3-O-a-L-arabinopyranosyl-
(1!2)-a-L-rhamnopyranoside (Bp2) and quercetin-3-O-
rhamnopyranoside (Bp3). These three compounds are considered
as potential candidates for specific markers of this species and can
be used in authenticating its raw material (dos Santos Nascimento
et al., 2018). In addition, they present relevant preclinical
pharmacological evidence, especially antioxidant, anti-
inflammatory, and immunosuppressive activities (Muzitano et al.,
2006; Ferreira et al., 2014; Sobreira et al., 2017).
It is believed that plants that are rich in phenolic compounds
(e.g., quercetin and kaempferol) like B. pinnatum couldFrontiers in Pharmacology | www.frontiersin.org 3constitute possible alternatives in preventing and treating
chronic inflammation, as well as autoimmune abnormalities
(Samsami-kor et al., 2015). Clinical studies have demonstrated
that phenolic supplementation can improve quality of life in
patients with active mild to moderate UC, at least partially
through a reduction of inflammatory markers (Hanai et al., 2006;
Lang et al., 2015; Samsamikor et al., 2016). Thus, the objective of
this study was to evaluate the intestinal anti-inflammatory effects
of hydroethanolic extract from B. pinnatum leaf (HEBP) in
two experimental models of intestinal inflammation: 2.4-
dinitrobenzene sulfonic (DNBS) model in rats, and oral dextran
sulfate sodium (DSS) in mice.MATERIAL AND METHODS
Reagents and Plant Material
Most of the chemicals used were purchased from Sigma-Aldrich
chemical (São Paulo, Brazil; Madrid, Spain) unless otherwise
stated. Bp1 (99.3% purity), Bp2 (98.9% purity) and Bp3 (99.6%
purity) were previously isolated from Bryophyllum pinnatum in
our laboratory and identified by nuclear magnetic resonance
(NMR) and mass spectrometry (MS). The purity of the isolated
compounds was determined by software of ultra-fast liquid
chromatography coupled with a diode-array detector (UFLC-
DAD) (Shimadzu Model LC-20AD, with DAD detector model
SPD-M20A). NMR analysis of each sample also showed
integration signals related to one compound (results not
shown). Bryophyllum pinnatum (available at www.theplantlist.
org) leaf were collected from the “Escola Agrıćola de Jundiaı”́ in
Macaıb́a city, Rio Grande do Norte state, Brazil, in March of
2017. The botanical identification voucher specimen (No. 57335)
was deposited at the herbarium of the Bioscience Center of the
Federal University of Rio Grande do Norte. The collection was
authorized by the Brazilian Authorization and Biodiversity
Information System (SISBIO process No. 35017) and the
research was authorized by the National System for the
Management of Genetic Heritage and Associated Traditional
Knowledge (SISGEN process No. A7EA798).
HEBP Preparation and Quantitative
Analyses of Major Flavonoids by UFLC-
DAD
Fresh B. pinnatum leaf (3.8 kg) were processed by turbo
extraction with ethanol:water (1:1, v/v) for 5 min to obtain the
HEBP. The extract was filtered and concentrated on a
rotoevaporator (model V-700, Buchi) and freeze-dried
(extraction yield of 1.87%). One part of each freeze-dried HEBP
were analyzed by UFLC-DAD (Shimadzu Model LC-20AD, with
DAD detector model SPD-M20A). The method used was
validated according to the parameters of Brazilian legislation
No. 166 from 24 July 2017, which is aligned with the Guideline
Q2 (R1) do International Conference on Harmonisation of
Technical Requirements for Registration of Pharmaceuticals for
Human Use (ICH, 2005): selectivity, linearity, limits of detection
(LOD) and quantification (LOQ), precision, accuracy, content,July 2020 | Volume 11 | Article 998
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suitability of the developed method was verified according to
the parameters established in the United States Pharmacopeia
(USP) to guarantee resolution (R > 1.5), column efficiency (P >
2,000), tailing factor (T ≤ 2.0), and capacity factor (k’ ≥ 2.0) for
each peak to be subsequently quantified (USP, 2003).
All analyses were performed in triplicate and the
relative standard deviation was calculated. The samples were
resuspended in 1:1 methanol:water (v/v), and the final
concentration was 2 mg/mL for the extracts. A Phenomenex
Kinetex Core-Shell RP-18 column (150x4.6 mm, 2.6 mm particle
size) equipped with a Phenomenex security guard column (4.0x2.0
mm ID) was used. The eluents were: (A) trifluoroacetic acid 0.3%
and (B) acetonitrile. The following gradient (v/v) was applied: 7–
15% B, 0–3 min; 15–20% B, 3–12 min; 20–22% B, 12–30 min; with
30 min total analysis time. Flow elution was 0.7 ml/min, and 12 ml
of each sample was injected. The UV-DAD detector was
programmed for wavelength 200–500 nm and the chromatogram
was plotted at 254 nm and 340 nm. B. pinnatum is a plant rich in
flavonoids, then the chromatogram was analyzed at UV 340 nm,
but also recorded at UV 254 nm to verify the presence or absence
of other possible secondary metabolites (Aparicio and
Harwood, 2013).
In Vivo Studies
A total of 72 animals were included in this investigation. Female
Wistar rats (180 ± 20 g, 6-8 weeks old) were used for the colitis
induced by intra-colonic administration of DNBS (25 mg) in a
50% (v/v) ethanol/water solution (Morampudi et al., 2014). The
animals were fasted overnight and anesthetized with ketamine
(50 mg/kg) and xylazine (5 mg/kg) by intraperitoneal (IP) route.
Male C57BL/6J mice (7–9 weeks old) were used for colitis
induced by oral administration of 3% (w/v) DSS (36–50 KDa,
MP Biomedicals, Ontario, USA) (Vezza et al., 2017). All animals
were raised in accordance with the National Institute of Health
Guide for Laboratory Animals. Rodents were acclimated for 7
days prior to experimentation and housed under standard
environment conditions at 20–25°C and 12 h dark/light cycle
and had free access to potable water (ad libitum) and standard
food. These procedures were approved by the Ethics Committee
of Laboratory Animals of the University of Granada (Spain) (Ref.
No. CEEA-2010-286) and by the Federal University of Rio
Grande do Norte (CEUA No. 26/2016 and No. 60/2017).
DNBS-Induced Colitis: Experimental Design and
Treatment Protocol
Female Wistar rats (n = 40) were randomized into five groups
(n = 8/groups): control groups (non-colitic and colitic: DNBS),
HEBP (250 mg/kg and 500 mg/kg) and sulfasalazine (SSZ; 250
mg/kg). The vehicle (water; control groups), the extract, and the
sulfasalazine were orally administered for two days before the
colitis induction and three days after the induction. On day 3,
under light anesthesia (ketamine (50 mg/kg) and xylazine (5 mg/
kg); IP) and fasted overnight, animals kept in head-down
positions were given DNBS (0.5 ml; for 30s) through a Teflon
cannula (2 mm diameter) inserted 8 cm into the anus. Rats fromFrontiers in Pharmacology | www.frontiersin.org 4the non-colitic group intracolonically received 0.5 ml of 0.9%
saline. The rats were returned to their cages after the procedure
to recover from anesthesia.
Animals from all groups (n= 8) were then euthanized by
cervical dislocation under anesthesia (ketamine (80 mg/kg) and
xylazine (10 mg/kg); IP) 72 h after colitis induction. Colonic
segments were subsequently opened longitudinally after
euthanasia. The macroscopic damage score (MDS) was calculated
according to the criteria described by Bell et al. (1995).
Representative samples were frozen at -80°C and used for
determining myeloperoxidase activity (MPO), total glutathione
(GSH), malonaldialdehyde content (MDA), cytokine levels, and
reverse transcription−quantitative polymerase chain reaction (RT-
qPCR). Representative samples were taken from the distal inflamed
area for the histological and immunohistochemistry studies.
DSS-Induced Colitis: Experimental Design and
Treatment Protocol
Male C57BL/6J (n = 32) mice were randomized into four groups
(n = 8/groups): control groups (non-colitic and colitic: DSS), and
HEBP (100 mg/kg and 200 mg/kg). In this model, mice from the
DSS group and the HEBP treated groups received drinking water
(ad libitum) supplemented with 3% (w/v) DSS for 6 days (Melgar
et al., 2005). Mice were treated by oral gavage with the extract or
water (control groups) during the experimental period. The
animals were then euthanized after 9 days with cervical
dislocation under anesthesia (ketamine (80 mg/kg) and
xylazine (10 mg/kg); IP). The colonic samples were frozen at
-80°C for RT-qPCR analysis. Representative samples were taken
from the distal inflamed area for the histological and
immunohistochemistry studies.
Evaluation of DAI and Weight/Length
Colonic Relationship on DNBS-Induced
and DSS Colitis
The disease activity index (DAI) was determined by combining
scores of weight loss, stool consistency and bleeding, as
previously described by Cooper et al. (1993). The sum of the
points for body weight loss percentage (%) (score 0–4), stool
consistency (score 0–4) and rectal bleeding (score 0-4) were
calculated from according to Kim et al. (2012). DAI was scored
daily after colitis induction in the DNBS and DSS models. The
colon was cut near the ileocecal valve in all animals (n = 72), and
its length (cm) and weight (g) were measured. The weight/length
(g/cm) colonic relationship was then determined.
Determination of Myeloperoxidase (MPO)
Activity, Malonyldialdehyde (MDA) Levels,
and Glutathione (GSH) Total in the
Intestine
For these analyzes, colonic samples obtained from Wistar rats
(model DNBS) were used, cut uniformly and longitudinally,
perforated and preserved at -80°C. The MPO activity was
measured according to the technique described by Krawisz
et al. (1984). The samples (n = 8) were homogenized in 0.5%July 2020 | Volume 11 | Article 998
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The homogenate was centrifuged (2,000×g at 4°C for 20 min)
and the supernatant was used to measure MPO activity. Results
were expressed as MPO units per gram of wet tissue; one unit of
MPO activity was defined as that degrading 1 mmol hydrogen
peroxide/min at 25°C. MDA level was measured via the assay
described by Esterbauer and Cheeseman (1990). Colon samples
(n = 8) were suspended in buffer Tris hydrochloride (1:5 w/v)
and minced with scissors for 15 s on an ice-cold plate. The
resulting suspension was homogenized for 2 min with an
automatic Potter homogenizer and centrifuged at 2,500×g at 4°
C for 10 min. The supernatants were assayed to determine MDA
levels. The results are expressed as nanomoles of MDA per gram
of tissue. Total GSH content was measured via the assay
described by Anderson (1985). The colonic tissue (n = 8) was
homogenized with 5% trichloroacetic acid (1:20 w/v). Samples
were centrifuged at 10,000×g at 4°C for 15 min. The supernatant
was used to measure total GSH content. The results were
reported as units of GSH per milligram of tissue. The
absorbance of MPO activity, MDA levels and total GSH
content were measured at a wavelength (l) of 450, 586, and
412 nm, respectively.
Measurement of Cytokine Production in
the Intestine
The colonic tissue of Wistar rats was homogenized with
phosphate-buffered solution (PBS) (Safieh-Garabedian et al.,
1995). IL-1b and TNF-a levels in the rats were determined in
colon homogenate supernatants (DNBSmodel) using commercial
enzyme-linked immunosorbent assay (ELISA) kits (R&D
Systems, Minneapolis, MN) according to the manufacturer’s
instructions. The absorbance was measured at 490 nm and the
results were expressed as ng/g of homogenized tissue.
Analysis of RNA Transcripts by RT-qPCR
Total ribonucleic acid (RNA) in the colon was extracted using
a deoxyribonucleic acid (DNA) extraction kit, and its
concentration and purity were measured using NanoDrop
2000. Total RNA from colonic samples was reverse transcribed
to cDNA and the analysis of gene expression of inflammatory
mediators and proteins involved in epithelial integrity was
performed through Eco™ PCR real-time optical system
(Illumina, San Diego, CA, USA) with specific primers at 10 µM
of forward (FW) and reverse (RV) (Table 1). mRNA expression
was normalized using the housekeeping gene glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) and b-actin (Actb) as
internal control. The mRNA relative quantification was
calculated using the DDCt method.
Histopathology and Immunohistochemical
Analysis
The cross-sections (5 animals per group) of the colonic tissue
(inflamed area) were fixed in buffered paraformaldehyde (10% in
PBS, pH 7.2) in both experiments, and then processed by
histopathological standards and the immunohistochemicalFrontiers in Pharmacology | www.frontiersin.org 5technique. Cross-sections were selected and embedded in
paraffin. Tissue sections (5 mm) were obtained with a microtome
and stained with hematoxylin and eosin for histological evaluation
by optical microscopy. The histological microscopic damage index
(MIDI) was scored on a scale from 0 to 6, as reported by Zea-
Iriarte et al. (1996). Thin colon sections (3 mm) of 5 animals per
group were obtained with a microtome and transferred to gelatin-
coated slides for immunohistochemical analysis. Each tissue
section was then deparaffinised, rehydrated and washed with
0.3% Triton X-100 in PBS, quenched with endogenous
peroxidase (3% hydrogen peroxide). The colonic tissue was
incubated overnight at 4°C with the following primary
antibodies: NF-kB p65 1:100, iNOS 1:500; IL-17 1:800,
cyclooxygenase (COX) 2 1:500 (Santa Cruz Biotechnology,
Interprise, Brazil). Immunoreactivity was visualized using a
colorimetric-based detection kit following the protocol provided
by the manufacturer (TrekAvidin-HRP Label + Kit from Biocare
Medical, Dako, USA). The cell immunostaining intensity wasTABLE 1 | Primer sequences used in reverse transcription−quantitative
polymerase chain reaction (RT-qPCR) assays for in vivo models [2.4-
dinitrobenzene sulfonic acid (DNBS) and dextran sulfate sodium (DSS)].
Gene Organism Sequence 5’-3’ melting
T °C
Actb Rat FW : CCATCACCATCTTCCAGGAG
RV : CCTGCTTCACCACCTTCTTG
60
GAPDH Mouse FW : CCATCACCATCTTCCAGGAG
RV : CCTGCTTCACCACCTTCTTG
60
IL-1b Rat FW: GATCTTTGAAGAAGAGCCCG
RV: AACTATGTCCCGACCATTGC
60
IL-1b Mouse FW : TGATGAGAATGACCTCTTCT
RV : CTTCTTCAAAGATGAAGGAAA
55
TNF-a Rat FW: GTCTTTGAGATCCATGCCATTG
RV: AGACCCTCACACTCAGATCA
57
TNF-a Mouse FW: AACTAGTGGTGCCAGCCGAT
RV: CTTCACAGAGCAATGACTCC
60
iNOS Mouse FW : GTTGAAGACTGAGACTCTGG
RV: ACTAGGCTACTCCGTGGA
67
IL-6 Mouse FW: TAGTCCTTCCTACCCCAATTTCC
RV: TTGGTCCTTAGCCACTCCTTCC
60
OCLUDINA Mouse FW : ACGGACCCTGACCACTATGA
RV : TCAGCAGCAGCCATGTACTC
56
ICAM-1 Mouse FW : GAGGAGGTGAATGTATAAGTTATG
RV : GGATGTGGAGGAGCAGAG
60
MUC-2 Mouse FW: GCAGTCCTCAGTGGCACCTC
RV: CACCGTGGGGCTACTGGAGAG
60
MUC-3 Mouse FW: CGTGGTCAACTGCGAGAATGG
RV: CGGCTCTATCTCTACGCTCTC
60
Z0-1 Mouse FW: GGGGCCTACACTGATCAAGA
RV: TGGAGATGAGGCTTCTGCTT
56
TFF-3 Mouse FW: CCTGGTTGCTGGGTCCTCTG
RV: GCCACGGTTGTTACACTGCTC
60
VILLIN Mouse FW: TGCTACCTGCTGCTCTATACCTAC
RV : CTGGCTCGTCGTTGTACTTCTG
60
TLR-4 Mouse FW: GCCTTTCAGGGAATTAAGCTCC
RV: AGATCAACCGATGGACGTGTAA
60
MCP-1 Mouse FW: CAGCTGGGGACAGAATGGGG
RV: GAGCTCTCTGGTACTCTTTTG
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and immunohistochemical analyses were performed independently
by two pathologists, blinded to group identity.
Statistical Analysis
All results were expressed as means ± standard error of the
means. Differences between means were tested for statistical
significance using one-way ANOVA followed by Tukey test.
Non-parametric data (score) are expressed as the median (range)
and were analyzed using the Mann-Whitney test. All statistical
analyzes were performed using GraphPad 6.1 software (Graph-
Pad Software Inc., La Jolla, CA) and statistical significance was
set at p < 0.05.Frontiers in Pharmacology | www.frontiersin.org 6RESULTS
UFLC-DAD Profile and Quantitative
Analyses of Major Flavonoids of the HEBP
Figure 1 shows the HEBP chromatogram with a main peak and
other peaks at UV 254 and 340 nm, corresponding to the
flavonoids: Bp1, Bp2, and Bp3. Extract peaks were identified by
comparing retention times, UV spectra data and increasing
peak areas by co-injection (extract + standard solutions, 1:1, v/
v). Most of the peaks found have already been identified and
previously described by our research group (Fernandes et al.,
2016), but this is the first time that the content of major





FIGURE 1 | Chromatogram of hydroethanolic extract from B. pinnatum leaf (HEBP) at UV 254 (A) and 340 (B) nm and chromatogram at UV 340 nm of Bp1 (C),
Bp2 (D), and Bp3 (E). Stationary phase: C18 Phenomenex (150x4.6 mm, 2.6 mm) equipped with a Phenomenex security guard column (4.0x2.0 mm ID). Mobile
phase: trifluoroacetic acid 0.3% and (B) acetonitrile; gradient: 7–15% B, 0–3 min; 15–20% B, 3–12 min; 20–22% B, 12–30 min; flow elution 0.7 ml/min; detection
254 and 340 nm.July 2020 | Volume 11 | Article 998
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the major flavonoids identified in the B. pinnatum leaf extract
by high-performance liquid chromatography coupled with
DAD-MS/MS are flavonoids-O-glycosides derived from
aglicones eupafolin, quercetin, and kaempferol. In this work,
the major flavonoid, Bp1, and other two compounds Bp2 and
Bp3 were quantified as possible analytical markers this species.
The UFLC-DAD method for the quantification of flavonoids
indicated good linearity (r > 0.9997:Bp1; r > 0.9996:Bp2; r >
0.9988:Bp3), specificity, selectivity, precision, robustness and
accuracy (Table 2). The Bp1, Bp2 and Bp3 contents were 35.56 ±
0.086 mg, 4.66 ± 0.076 mg and 4.56 ± 0.026 mg, respectively,
per g of extract (Table 2).
Preventive Effect of HEBP on DNBS-
Induced Colitis in Rats
The colonic instillation of DNBS (DNBS-induced colitis on day
3, Figure 2A) caused intestinal inflammation, which was
evidenced over the course of the experiment by body weight
loss (days 4 and 5, Figure 2B, p < 0.05), the presence of diarrhea
and blood in the feces from rats in the DNBS group, parameters
evaluated in the DAI (Figure 2C). The macroscopic
characterization (Figure 2D) of the colonic tissue in these rats
revealed the presence of an extensive area of inflammation
and ulceration, with high MDS values (Figure 2E) and a
significant increase (p < 0.05) in the colonic weight/length
ratio (Figure 2F) when compared to the non-colitic group.
Preventive administration of HEBP (250 and 500 mg/kg) or
SSZ (250 mg/kg) had a beneficial effect on intestinal
inflammation, evidenced by attenuating body weight loss
(day 4) and a reduction in the DAI score (p < 0.05), in the
MDS (p < 0.05) and in the weight/length ratio (p < 0.05) of the
colon when compared to the DNBS group.
In comparison with the non-colitic group, the colonic
inflammation in the DNBS group was associated with
increased (p < 0.05) MPO activity (Figure 3A1), TNF-a
(Figure 3A2) and IL-1b (Figure 3A3) pro-inflammatory
cytokine levels, and MDA (Figure 3B1), as well as depleted
GSH content (Figure 3B2). In turn, the anti-inflammatory
and antioxidant effect of HEBP (250 mg/kg or 500 mg/kg) and
SSZ (250 mg/kg) was also evidenced by a significant
improvement (p < 0.05) in these markers (MPO, MDA,
GSH, IL-1b, and TNF-a) in relation to the DNBS group.
Moreover, the colonic damage induced by DNBS (25 mg;
intracolonic route) was also characterized by increased (p <
0.05 vs non-colitic rats) gene expression of NF-kB p65 and
ICAM-1 (Figure 4A1, 2), as well as by decreased (p < 0.05 vs
non-colitic rats) gene expression of different markers involved
in epithelial barrier integrity: ZO-1, occludin and MUC-2
(Figure 4B1–3) in the DNBS group. The pre-treatment with
HEBP (250 or 500 mg/kg) or SSZ (250 mg/kg) resulted in a
s ign ificant decrease (p < 0 .05) in the express ion
(downregulation) of NF-kB p65 and ICAM-1 in comparison
with the DNBS group; as well as in increased expression
(upregulation) of ZO-1, occludin and MUC-2 showing
significant statistical differences (p < 0.05) for ZO-1 with
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Andrade et al. Anti-Inflammatory and Chemopreventive Effects of Bryophyllum pinnatumFurthermore, HEBP (250 and 500 mg/kg) did not statistically
differ (p ≥ 0.05) from SSZ 250 mg/kg in all cases.
The histological evaluation (Figure 5i) of the colonic
specimens from DNBS assay confirms the anti-inflammatory
activity of HEBP and SSZ. Intense transmural inflammation was
observed when comparing the colon structure of the non-colitic
group (Figure 5A) with the DNBS group (Figure 5B),
comprising the mucosa and submucosa layers with extensive
superficial ulceration, resulting in almost complete destruction of
the crypts, absence of goblet cells and presence of edema.Frontiers in Pharmacology | www.frontiersin.org 8Treatment with HEBP (250 and 500 mg/kg; Figures 5C, D) and
SSZ (250 mg/kg; Figure 5E) attenuated this DNBS-induced
colonic damage, reduced inflammatory infiltrate and edema,
and promoted epithelial regeneration, as evidenced by reduced
MIDI (Figure 5F, p < 0.05). The immunohistochemistry data
(Figure 5ii) corroborate the findings described above, showing
that DNBS caused an increase in immunoreactivity for NF-kB
p65, IL-17, COX 2, and iNOS mediators (Figures 5G–V). On the
other hand, the groups subjected to treatment with HEBP 250





FIGURE 2 | 2.4-dinitrobenzene sulfonic acid (DNBS)–induced colitis experimental design (A) and effects of treatments with hydroethanolic extract from B. pinnatum
leaf (HEBP) on weight loss (B), damage of the colon (C), macroscopic damage score (MDS) (D), weight/length ratio (E), and disease activity index (DAI) (F). Data
(n = 8) are presented as mean ± standard error from the mean. ***p < 0.001, ****p < 0.0001 compared with non-colitic group; #p < 0.01, ###p < 0.001,
####p < 0.0001 compared with DNBS group; qp < 0.05 compared with SSZ 250 mg/kg group.July 2020 | Volume 11 | Article 998
Andrade et al. Anti-Inflammatory and Chemopreventive Effects of Bryophyllum pinnatumof NF-kB p65, IL-17, COX-2, and iNOS, which was confirmed by
the immunohistochemical score (Figures 5W-Z, p < 0.05).
Effect of HEBP on DSS-Induced Colitis in
Mice
After colitis induction (day 1, Figure 6A), the daily weight, food
intake, and water consumption of mice from each group were
recorded and analyzed in the DSS experiment. The non-colitic
group had normal food and drinking water intake, and their
body weight showed an irrelevant variation. DSS (3% in drinking
water; w/v) intake caused weight loss (Figure 6B, p < 0.05 vs non-
colitic group) in the mice of the DSS and HEBP (100 and 200
mg/kg) groups from day 4, which was associated with diarrhea
and the presence of blood in the feces. This resulted in increased
DAI values (Figure 6C) over time. However, DSS-colitic mice
treated with HEBP at doses of 100 or 200 mg/kg significantly
reduced (p < 0.05) the DAI score in the days following the
interruption of DSS administration (day 6) when compared to
the DSS group. The colon was isolated and its length was
measured with a ruler and inflammation and ulceration areas
was analyzed (Figure 6D). The results showed that the colon was
longer in the mice from the non-colitic group than in the mice
from the DSS group. The extract (100 and 200 mg/kg) attenuated
the colon shortening and decreased the inflammation andFrontiers in Pharmacology | www.frontiersin.org 9ulceration areas in the DSS-induced group. No significant
differences (p ≥ 0.05) were observed in the weight/length ratio
(Figure 6E) of the colon when compared to the DSS group once
the mice were sacrificed, although a decreasing trend was
observed with the higher assayed dose.
In comparison with non-colitic mice, DSS colitis was associated
with changes in the intestinal immune response, as evidenced by
the increased (p < 0.05) colonic expression of different pro-
inflammatory markers, including Toll-like receptor 4 (TLR-4),
chemokines (MCP-1 andMIP-2), ICAM-1, cytokines (TNF-a, IL-
1b, IL-6), and iNOS (Figures 7A1–7, B1). Treatment with HEBP
(100 and 200 mg/kg) in colitic mice reduced (p < 0.05) the gene
expression of all these inflammatory and oxidative markers (TLR-
4, MCP-1, MIP-2, ICAM-1, TNF-a, IL-1b, IL-6, and iNOS) in
comparison to the DSS group. In addition, DSS-induced colitis
compromised the intestinal barrier function, as shown by the
decreased (p < 0.05) expression of different proteins involved in
maintaining epithelial integrity, including TFF-3, villin, ZO-1,
occludin, MUC-2, and MUC-3 (Figures 7C1–6) when
compared to the non-colitic group. The administration of HEBP
to colitic mice increased (p < 0.05 vs DNBS group) the colonic
expression of TFF-3 and villin when compared to the DSS group.
An increasing trend was observed in the expression of ZO-1,
occluding, and MUC-2 (p ≥ 0.05 vs DNBS group) and MUC-3A
B
FIGURE 3 | Effect of hydroethanolic extract from B. pinnatum leaf (HEBP) on inflammation markers (A): myeloperoxidase activity (MPO) (A1), TNF-a (A2), and IL-1b
(A3) and oxidative markers (B): malonaldialdehyde content (MDA) (B1) and GSH (B2) in the intestinal inflammation of the experimental 2.4-dinitrobenzene sulfonic
acid (DNBS) model. Data (n = 8) are presented as mean ± standard error from the mean. ***p < 0.001, ****p < 0.0001 compared with non-colitic group; #p < 0.05,
##p < 0.01, ###p < 0.001, ####p < 0.0001 compared with DNBS group; qp < 0.05, compared with SSZ 250 mg/kg group.July 2020 | Volume 11 | Article 998
Andrade et al. Anti-Inflammatory and Chemopreventive Effects of Bryophyllum pinnatumexpression was significantly increased (p < 0.05 vs DNBS group)
by HEBP administration at the 100 mg/kg dose.
The histological (Figure 8i) analysis and immunostaining
(Figure 8ii) of the NF-kB p65, IL-17, COX-2, and iNOS
antibodies reinforced the pre-clinical efficacy of the HEBP extract
in the DSS model. When comparing to the colon structure of the
non-colitic group (Figure 8A) the colonic specimens from the DSS
group (Figure 8B) showed intense transmural inflammation, which
affected the mucosa and the submucosa. Lesions were found in the
colonic tissue, including extensive mucosal ulceration and almost
complete destruction of the crypts, absence of goblet cells, and
edema formation were observed in these mice from the DSS group.
Administrating extract (HEBP 100 and 200 mg/kg, Figures 8C, D)
to colitic mice resulted in improving the histological damage
induced by DSS, as characterized by epithelial regeneration,
decreased inflammatory infiltrate and edema. These data were
corroborated by histopathological score (Figure 8E, p < 0.05 vs
DSS group). In addition, the HEBP (100 and 200 mg/kg) decreased
immunoreactivity of NF-kB p65, IL-17, COX-2, and iNOS proteins
(Figures 8F–R) as well as the immunohistochemical scores (Figures
8S-V, p < 0.05 vs DSS group).DISCUSSION
Human IBD (CD and UC) are characterized by abnormal
activation of the gut immune system, which results in localFrontiers in Pharmacology | www.frontiersin.org 10chronic inflammation (Barone et al., 2018). The experimental
models (DNBS and DSS) used in this study predict results in
humans and are crucial to consider the real-life context of the
disease. The present research reveals that HEBP exerts intestinal
anti-inflammatory effects on experimental colitis models in
rodents, since it was able to prevent the colonic damage induced
by DNBS in rats and to improve the DSS-associated colonic
inflammation in mice. These effects were evidenced by
improvement in the different parameters evaluated in the DAI
(diarrhea, weight loss and the presence of blood in feces), as well as
of the intestinal macroscopic and histopathological damage. The
main compounds previously identified in the HEBP (a potential
phytotherapeutic plant extract) were quercetin- and kaempferol-
derived flavonoid glycosides (Muzitano et al., 2006; Cruz et al.,
2012; Fernandes et al., 2016). These flavonoids showed beneficial
effects on intestinal inflammation in the same experimental colitis
models (DNBS and DSS) (Salaritabar et al., 2017).
In fact, both DNBS (intracolonic route) and DSS (orally)
models are considered adequate to study the immunoregulatory
pathways in intestinal inflammation, which are closely linked to
the pathogenesis of IBD (Valatas et al., 2013). In this sense, one
of the main mechanisms involved in the intestinal inflammatory
process is T cell activation (Valatas et al., 2013). Regulation of the
differentiation and proliferation of inflammatory Th in the Th1,
Th2 and Th17 subgroups can be initiated by TLR activation
(especially TLR-4) after rupture of intestinal homeostasis (Lu
et al., 2018). TLR are transmembrane proteins (glycoproteins)A
B
FIGURE 4 | Effect of hydroethanolic extract from B. pinnatum leaf (HEBP) on colonic gene expression of different mediators in 2.4-dinitrobenzene sulfonic acid
(DNBS)–induced colitis analyzed by reverse transcription−quantitative polymerase chain reaction (RT-qPCR). Inflammation markers (A): NF-kB p65 (A1), ICAM-1
(A2), and markers involved in epithelial barrier integrity (B): ZO-1 (B1), occludin (B2), and MUC-2 (B3). Data (n = 8) are presented as mean ± standard error from the
mean. **p < 0.01, ***p < 0.001, ****p < 0.0001 compared with non-colitic group; #p < 0.05, ##p < 0.01, ###p < 0.001, compared with DNBS group.July 2020 | Volume 11 | Article 998
Andrade et al. Anti-Inflammatory and Chemopreventive Effects of Bryophyllum pinnatumand are expressed in cells of both the innate and adaptive
immune systems (monocytes, macrophages, lymphocytes, mast
cells, dendritic cells), as well as in the intestinal epithelium
(Sipos, 2014).Frontiers in Pharmacology | www.frontiersin.org 11Activation of TLR by components which induce the immune
response (i.e. DNBS and DSS) causes recruitment of interleukin-
1 receptor-associated kinase 1 (IRAK-1) and 4 (IRAK-4) which
stimulate tumor necrosis factor receptor-associated factor 6FIGURE 5 | Histopathologic features of representative samples of colonic tissue (i), showing the colon fragment cut in the longitudinal direction and stained with
Hematoxylin/Eosin; scale 100 mm: non-colitic (A), 2.4-dinitrobenzene sulfonic acid (DNBS) (B), hydroethanolic extract from B. pinnatum leaf (HEBP) 250 and 500
mg/kg (C–D), SSZ 250 mg/kg (E), and evaluation of microscopic damage (F). Normal intestinal layers ( ), diffused active colitis with superficial erosions, stromal
edema, dense acute and chronic inflammatory cells infiltrate with widely ( ), moderate ( ), light ( ) ulcerating mucosa, and loss of goblet cells ( ).
Immunohistochemical analysis of colonic tissue and immunohistochemistry scores (ii). Scale bar 100µm. The non-colitic (G-J), DNBS (K–N), HEBP 250 mg/kg
(O–R) and SSZ 250 mg/kg (S–V) groups were analyzed by immunoreactivity for NF-kB p65, IL-17, COX-2, and iNOS. Arrows indicate antibody reactivity,
indicates area of intense inflammatory cell infiltration, dashed areas indicate ulceration. Data (n = 8) are presented as mean ± standard error from the mean.
*p < 0.05, **p < 0.01, ***p < 0.001, compared with non-colitic group; #p < 0.05, ##p < 0.01, compared with DNBS group; qp < 0.05, qqp < 0.01, compared with
SSZ 250 mg/kg group.July 2020 | Volume 11 | Article 998
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(TAK1), which in turn generates activation of the IKK kinase
complex. Such a complex promotes phosphorylation and
degradation of IkB-a (Inhibitor kappa B-alpha), resulting in
the dissociation and release of NF-kB p65, known as an
important factor in regulating this highly expressed immune
process in patients with IBD (Trzeciak-Jędrzejczyk et al., 2017;
Yao et al., 2017; Lu et al., 2018). The NF-kB p65 migrate to the
nucleus of cells and downregulate or supra-regulate the
expression genes associated with the transcription of different
inflammatory mediators (IL-12, IL-18, IL-23, IL-6, IL-1b, IL-10,
TNF-a, and prostaglandins), activator protein 1, granulocyte-
macrophage colony-stimulating factor, intercellular adhesion
molecules, and inflammatory enzymes (iNOS and COX) (Yao
et al., 2017; Ramos and Papadakis, 2019).Frontiers in Pharmacology | www.frontiersin.org 12Based on this information, treatment with HEBP (orally) was
able to prevent the abnormal increase of colonic TLR-4 expression,
probably by limiting the activation of the subsequent signaling
cascade, i.e., it decreased mRNA expression and immunoreactivity
of NF-kB p65, IL-17 and COX-2. In turn, this downregulation may
be associated with a reduction in some of the evaluated pro-
inflammatory cytokines (TNF-a, IL-1b and IL-6). The inhibition
of the inflammatory response exerted by HEBP in DNBS- and DSS-
induced colitis is most probably due to the presence of the phenolic
compounds in the extract, which directly or indirectly prevent the
activated inflammatory pathways: TLR-4, NF-kB p65, COX-2, or
IL-17, thus contributing to restoring the intestinal homeostasis. In
fact, inhibition in the production of TLR-4, NF-kB p65, COX-2, IL-
17, TNF-a, IL-1b, and IL-6 is considered useful in treating colitis





FIGURE 6 | Dextran sulfate sodium (DSS)–induced colitis experimental design (A) and effects of treatments with hydroethanolic extract from B. pinnatum leaf
(HEBP) on weight loss (B), disease activity index (DAI) (C), damage (D), and weight/length ratio (E) of the colon. Data (n = 8) are presented as mean ± standard error
from the mean. ****p < 0.0001 compared with non-colitic group; #p < 0.05, ##p < 0.01, ###p < 0.001, ####p < 0.0001 compared with DSS group.July 2020 | Volume 11 | Article 998
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FIGURE 7 | Effect of hydroethanolic extract from B. pinnatum leaf (HEBP) on colonic gene expression of different mediators in dextran sulfate sodium (DSS)–induced
colitis analyzed by reverse transcription−quantitative polymerase chain reaction (RT-qPCR). Inflammation markers (A): TLR-4 (A1), MCP-1 (A2), MIP-2 (A3), ICAM-1
(A4), TNF-a (A5), IL-1b (A6), IL-6 (A7), oxidative marker (B): iNOS (B1) and markers involved in epithelial barrier integrity (C): TFF-3 (C1), villin (C2), ZO-1 (C3),
occludin (C4), MUC-2 (C5), and MUC-3 (C6). Data (n = 8) are presented as mean ± standard error from the mean. **p < 0.01, ***p < 0.001, ****p < 0.0001
compared with non-colitic group; #p < 0.05, ##p < 0.01, ###p < 0.001, ####p < 0.0001 compared with DSS group.Frontiers in Pharmacology | www.frontiersin.org July 2020 | Volume 11 | Article 99813
Andrade et al. Anti-Inflammatory and Chemopreventive Effects of Bryophyllum pinnatumhighlighting the role of IL-6, which is a pro-tumorigenic cytokine
which affects cell proliferation, survival, differentiation, and
migration; in fact, the inhibition of IL-6 not only reduces
intestinal inflammation, but is also associated with decreased risk
of colorectal cancer in IBD patients (Waldner and Neurath, 2014).
In experimental colitis models, as well as in human IBD, the
intestinal inflammatory process is directly associated with the
induction of oxidative stress, which reduces the cellular
antioxidant capacity. The excessive production of free radicals
can react with the fatty acids of the cell membrane, in turn
leading to lipid peroxidation, and thus contributing to intestinal
oxidative damage (Safdari et al., 2016; Nikkhah-Bodaghi et al.,
2019). As a result, another mechanism which could justify the
beneficial effects of HEBP on these experimental colitis modelsFrontiers in Pharmacology | www.frontiersin.org 14can be associated with the antioxidant properties which it may
exert, mostly due to the presence of flavonoids, especially
quercetin and kaempferol. This effect was evidenced by the
increase in the colonic content of the antioxidant peptide GSH
and reduced MDA levels, a lipid peroxidation marker.
Moreover, it has been reported that excessive production of NO
in IBD causes deleterious effect to the tissue through the production
of ROS and RNS which are responsible for cytotoxic processes, such
as lipid peroxidation and DNA damage, thus resulting in
inflammation and tissue damage (Andrade et al., 2018; Simioni
et al., 2018). The results of the present study revealed that HEBP
reduced the gene expression and immunoreactivity of iNOS in the
colonic tissue of treated colitic mice. All these antioxidant effects can
play an important role in improving the pathogenic process whichFIGURE 8 | Histopathologic features of representative samples of colonic tissue (i), showing the colon fragment cut in the longitudinal direction and stained with
Hematoxylin/Eosin; scale 50 mm: non-colitic (A), DSS (B), HEBP 100 and 200 mg/kg (C, D), and the evaluation of microscopic damage (E). Normal intestinal layers
( ), diffused active colitis with superficial erosions, stromal edema, dense acute and chronic inflammatory cells infiltrate with widely ( ), moderate ( ), light ( )
ulcerating mucosa, and loss of goblet cells ( ). Immunohistochemical analysis of colonic tissue and immunohistochemistry scores (ii). Scale bar 50µm. The non-
colitic (F–I), DSS (J–M), and HEBP 100 mg/kg (O–R) groups were analyzed by immunoreactivity for NF-kB p65, IL-17, COX-2, and iNOS. Arrows indicate antibody
reactivity, indicates area of intense inflammatory cell infiltration, dashed areas indicate ulceration. Data (n = 8) are presented as mean ± standard error from the
mean. **p < 0.01, ***p < 0.001, compared with non-colitic group; #p < 0.05, ##p < 0.01, compared with DSS group.July 2020 | Volume 11 | Article 998
Andrade et al. Anti-Inflammatory and Chemopreventive Effects of Bryophyllum pinnatuminvolves neutrophil infiltration, and in turn ROS and RNS
overproduction in patients with IBD (Salaritabar et al., 2017).
The intensity and maintenance of the inflammatory response,
both in clinical and experimental IBD, are also determined by
coordinated mechanisms of cell recruitment, which comprise the
positive regulation of the expression of intercellular adhesion
molecules (ICAM-1) and chemokines (MIP-2 and MCP-1),
mainly by activated NF-kB p65 (Trzeciak-Jędrzejczyk et al., 2017;
Wang et al., 2018). Colonic inflammation in this study was
associated with increased mRNA expression of MIP-2, MCP-1
and ICAM-1, since these proteins recruit defense cells
(leukocytes) and favor their adhesion to the activated
endothelium at the inflammation site (Vainer, 2005; Abiodun
et al., 2016). The downregulation in the expression of the MIP-2
and MCP-1 chemokines, and of the ICAM-1 adhesion molecule by
the HEBP improved colonic inflammation in both experimental
colitis models, thus resulting in reduced migration and penetration
of inflammatory cells into the intestinal mucosa. This would explain
the reduction in inflammatory infiltrate and its deleterious impact
on the intestinal tissue observed in histological examinations.
Immune deregulation and the generation of ROS in IBD may
also be associated with the functional impairment of IEC
(enterocytes, goblet cells, neuroendocrine cells, Paneth cells, and
M cells). The expression and production of inflammatory mediators
alters the integrity and functionality of these cells, promoting a
rupture in the barrier of tight epithelial junctions and imbalance in
paracellular permeability (Vezza et al., 2017; Ramos and Papadakis,
2019). This was evidenced by decreased TFF-3, ZO-1, and occludin
expression, and aggravated by the reduction of MUC-2 (the main
constituent of the mucus layer in the colon), MUC-3 (a membrane-
bound mucin) and villin-1 in the colitic control group of the tested
experimental models. The gene expression of the proteins associated
with mucosa protection was slightly upregulated by the HEBP
treatment, presenting an increase which is relevant in TFF-3,
MUC-3, and villin-1 proteins. In fact, TFF-3 and villin-1 are
considered as parameters for goblet cell function, which play an
important role in the protection, restitution and healing of the
mucosa (Vezza et al., 2017), and highlight another potential
pharmacological property of the HEBP.
The treatment of colitis animals using different HEBP doses
resulted in improving most of the pro-inflammatory cytokines and
intestinal barrier proteins evaluated, revealing the contribution of
the immunomodulatory properties of the different flavonoids
present in the extract. Pretreatment with the extract in
the DNBS model enabled a protective condition in the animal’s
body against the development of the disease. Several investigations
have reported that one of the initial stages of IBD is related to
interruption of the barrier in the intestinal mucosa which results in
inflammation and dysregulation of mucosal homeostasis. When
this occurs, cells involved in innate immunity like macrophages
and dendritic cells can activate PRRs in epithelial cells, including
TLR (Mogensen, 2009). It can be proposed that one of the action
mechanisms of HEBP in IBD involves its ability to decrease the
gene expression of TLR-4, which reduces the deregulated
production of pro-inflammatory cytokines (COX-2, IL-17, TNF-
a, IL-1b, and IL-6), adhesion molecules (ICAM-1), andFrontiers in Pharmacology | www.frontiersin.org 15chemokine (MIP-2 and MCP-1) due to the down-regulation of
NF-kB p65.
These cytokines promote disruption of epithelial integrity,
facilitating access of the antigen to the submucosa, the activation
of immune cells, and the infiltration of leukocytes in the inflamed
tissue (Bribi et al., 2016; Yousefi et al., 2019). Infiltration of
activated leukocytes favors production and release of more pro-
inflammatory cytokines, thus playing a fundamental role in
inducing oxidative reactions in the intestinal mucosa. Another
action mechanism which can be proposed is that the extract has
the capacity to reduce leukocyte infiltration, and together with its
antioxidant property manages to maintain or recover the
integrity of the already compromised intestinal barrier. Thus,
HEBP has a fundamental role in regulating intestinal immune
homeostasis and the inflammatory responses. The results
obtained in the DNBS and DSS models indicate that HEBP has
both chemopreventive and anti-inflammatory effects.
Preclinical studies with intestinal inflammation models
conducted with plant extracts (e.g. Passiflora subpeltata, Citrus
aurantium, Ipomoea asarifolia) which contain phenolic
compounds derivatives (gallic acid, apigenin, catechin, luteolin,
quercetin, alpinetin, rutin) showed that their extracts have
significant intestinal anti-inflammatory effects due to their ability
to suppress levels of inflammatory and oxidative mediators
(da Silva et al., 2018; He et al., 2019; Shanmugam et al., 2020).
Park et al. (2012); Sotnikova et al. (2013); Mascaraque et al.
(2015); Carrera-Quintanar et al. (2018); Duan et al. (2020) and
Vezza et al. (2016) report that flavonoids (among them quercetin
and kaempferol) have shown remarkable effects in the attenuation
of intestinal inflammation in pharmacological studies (e.g. DNBS-
and DSS-model) in animals (rodents) and in clinical studies. As in
the present study, the researchers reported that the animals treated
(pre and/or post treatment) with a flavonoid- rich extract had
significantly lower DAI scores, a reduction in multiple tissue
injuries and ulceration, in the infiltration of inflammatory cells
and in the shortening of the crypts.
According to researchers, flavonoids suppressed the activation of
TLR-4/NF-kB p65 signaling pathway, leading to a decrease in gene
expression of TNF-a, IL-1B, and IL-6, COX-2, TFF-3, and iNOS
proteins in the intestinal mucosa in colitis model (Park et al., 2012;
Sotnikova et al., 2013; Vezza et al., 2016; Duan et al., 2020). Previous
reports also demonstrated the potential effects of treatment with B.
pinnatum leaf extracts as antioxidant and immunoregulator,
promoting down-regulation inflammatory markers (IL-6, IL-1b,
TNF-a, iNOS, NF-kB p65, and COX-2) in animal models for
allergic airway disease (Cruz et al., 2012), acute, and chronic skin
inflammation (Chibli et al., 2014), local inflammation induced by
Bothrops jararaca snake venom (Fernandes et al., 2016) and
showing a protective effect on gastric lesion (Sobreira et al., 2017;
de Araújo et al., 2018). The authors associated the pharmacological
response to the flavonoids present in the extracts.
In summary, this study provides pre-clinical evidence of the
intestinal anti-inflammatory effect of HEBP when administered
preventively (DNBS model) and in post-treatment curative
protocols (DSS model). HEBP modulated the inflammatory
response, reduced the expression of important pro-inflammatoryJuly 2020 | Volume 11 | Article 998
Andrade et al. Anti-Inflammatory and Chemopreventive Effects of Bryophyllum pinnatummarkers, decreased oxidative stress, and improved the integrity of
the intestinal barrier while also maintaining the cytoarchitecture of
colonic tissue. The beneficial effect of HEBP can be attributed to the
presence of quercetin- and kaempferol-derived flavonoids
glycosides, making it a potential therapeutic alternative in the
control of human IBD.
There are currently several therapeutic strategies available to treat
IBD. However, most treatments can be associated with serious
adverse effects. This justifies the search for new treatments which
can combine effectiveness with a low risk of adverse effects
(Samsami-kor et al., 2015). In this sense, we highlight the interest
in herbal products rich in bioactive metabolites, especially phenolic
compounds which are recognized by their immunomodulatory and
antioxidant properties, as is the case of HEBP. This extract showed
relevant pharmacological effects in preclinical assays. In view of this,
there is the potential to conduct some future clinical and about action
mechanism of compounds Bp1, Bp2 and Bp3 studies to ensure safe
and effective development of a phytotherapeutic treatment.DATA AVAILABILITY STATEMENT
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